Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells - PubMed (original) (raw)

Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells

G Y Ng et al. Endocrinology. 1997 Oct.

Abstract

Dopamine D2 receptor agonists are commonly used in the control of PRL-secreting adenomas, and the sensitivity of dopamine agonists during long term therapy is exquisite. However, the molecular mechanisms responsible for the maintenance of this cellular sensitivity to dopamine agonists remain poorly understood. In the present study, we examined the agonist-induced regulation of the human D2L receptor expressed to a specific activity of approximately 1 pmol receptor/mg protein in Sf9 insect cells. Treatment of D2L receptor-expressing cells with dopamine for up to 3 h resulted in no detectable change in the ligand-binding properties of the receptor and a approximately 120-fold reduction in the potency, but not the efficacy, of D2L receptors to mediate dopamine inhibition of forskolin-stimulated adenylyl cyclase activity. This resistance of the D2L receptor to agonist-induced desensitization was accompanied by a approximately 28% translocation of intracellular D2L receptors to the cell surface, as quantified by cellular fractionation and radioligand binding and visualized by whole cell immunocytochemical staining and confocal microscopy. Immunoblot analysis of the P2 membrane fraction revealed that surface D2L receptors comprised monomers and dimers. Treatment of D2L receptor-expressing cells with the protein synthesis inhibitor cycloheximide significantly reduced the basal expression level of receptors, but did not block the agonist-induced up-regulation of receptors. Longer periods of dopamine exposure for 24 h brought about a small increase in surface receptor density. However, when these studies were conducted in the presence of cycloheximide, receptor density was marginally reduced, suggesting that receptor synthesis accounts for the maintenance of cellular receptor density under these conditions. We conclude that the resistance of the D2L receptor-coupled adenylyl cyclase system to agonist-induced desensitization is attributed to the up-regulation of surface receptors after the translocation of existing intracellular receptors and de novo receptor synthesis.

PubMed Disclaimer

Cited by

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.
Adams B, Moghaddam B. Adams B, et al. J Neurosci. 1998 Jul 15;18(14):5545-54. doi: 10.1523/JNEUROSCI.18-14-05545.1998. J Neurosci. 1998. PMID: 9651235 Free PMC article.
Critical Impact of Different Conserved Endoplasmic Retention Motifs and Dopamine Receptor Interacting Proteins (DRIPs) on Intracellular Localization and Trafficking of the D2 Dopamine Receptor (D2-R) Isoforms.
Blagotinšek Cokan K, Mavri M, Rutland CS, Glišić S, Senćanski M, Vrecl M, Kubale V. Blagotinšek Cokan K, et al. Biomolecules. 2020 Sep 23;10(10):1355. doi: 10.3390/biom10101355. Biomolecules. 2020. PMID: 32977535 Free PMC article. Review.
Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.
Chauhan H, Killinger BA, Miller CV, Moszczynska A. Chauhan H, et al. Int J Mol Sci. 2014 Apr 8;15(4):5884-906. doi: 10.3390/ijms15045884. Int J Mol Sci. 2014. PMID: 24717411 Free PMC article.
Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium.
Gantz SC, Robinson BG, Buck DC, Bunzow JR, Neve RL, Williams JT, Neve KA. Gantz SC, et al. Elife. 2015 Aug 26;4:e09358. doi: 10.7554/eLife.09358. Elife. 2015. PMID: 26308580 Free PMC article.
Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes.
Vickery RG, von Zastrow M. Vickery RG, et al. J Cell Biol. 1999 Jan 11;144(1):31-43. doi: 10.1083/jcb.144.1.31. J Cell Biol. 1999. PMID: 9885242 Free PMC article.

Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells - PubMed (original) (raw)